Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 0.7x - 0.8x | 0.8x |
| Historical Pb Multiple | 0.4x - 1.0x | 0.7x |
| Fair Value | ₩10,569 - ₩11,682 | ₩11,126 |
| Upside | 26.9% - 40.2% | 33.6% |
| Benchmarks | - | Full Ticker |
| Kukje Pharma Co., Ltd. | - | KOSE:A002720 |
| Kyung Dong Pharmaceutical Co., Ltd. | - | KOSDAQ:A011040 |
| BCWORLD PHARM. Co., Ltd. | - | KOSDAQ:A200780 |
| Whan In Pharm Co.,Ltd. | - | KOSE:A016580 |
| JW Lifescience Corporation | - | KOSE:A234080 |
| Ahn-Gook Pharmaceutical Co., Ltd. | - | KOSDAQ:A001540 |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| A002720 | A011040 | A200780 | A016580 | A234080 | A001540 | |||
| KOSE:A002720 | KOSDAQ:A011040 | KOSDAQ:A200780 | KOSE:A016580 | KOSE:A234080 | KOSDAQ:A001540 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | -22.9% | NM- | 4.6% | 14.9% | 46.0% | ||
| 3Y CAGR | NM- | -24.4% | NM- | -4.3% | 50.5% | 62.3% | ||
| Latest Twelve Months | 166.3% | 130.7% | -674.5% | -38.8% | 75.5% | 97.2% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -0.1% | 2.8% | -3.2% | 12.6% | 10.6% | 2.4% | ||
| Prior Fiscal Year | -6.2% | -12.7% | 3.5% | 12.9% | 13.6% | 0.6% | ||
| Latest Fiscal Year | 3.3% | 2.8% | -5.9% | 9.0% | 19.8% | 6.2% | ||
| Latest Twelve Months | 2.7% | 3.0% | -6.6% | 7.5% | 18.5% | 4.5% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | -0.2% | 1.9% | -1.9% | 7.9% | 14.8% | 3.7% | ||
| Prior Fiscal Year | -10.6% | -8.5% | 3.3% | 8.6% | 18.8% | 0.8% | ||
| Latest Twelve Months | 4.8% | 2.7% | -6.4% | 5.3% | 25.3% | 7.9% | ||
| Next Fiscal Year | 7.8% | 1.0% | -11.5% | 6.1% | 26.0% | 22.5% | ||
| Two Fiscal Years Forward | 9.1% | 3.5% | -13.1% | 6.2% | 22.0% | 23.1% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 0.6x | 0.9x | 0.6x | 0.8x | 0.8x | 0.3x | ||
| Price / LTM EPS | 23.4x | 28.5x | -8.4x | 10.2x | 4.4x | 7.5x | ||
| Price / Book | 1.1x | 0.8x | 0.6x | 0.5x | 1.0x | 0.6x | ||
| Price / Fwd Book | 1.0x | 0.8x | 0.6x | 0.5x | 0.8x | 0.5x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 0.5x | 0.8x | 1.1x | |||||
| Historical P/B Ratio | 0.4x | 0.7x | 1.0x | |||||
| Selected P/B Multiple | 0.7x | 0.8x | 0.8x | |||||
| (x) Book Value | 162,798 | 162,798 | 162,798 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | A002720 | A011040 | A200780 | A016580 | A234080 | A001540 | |
| Value of Common Equity | 100,896 | 165,692 | 41,400 | 197,709 | 197,583 | 94,673 | |
| (/) Shares Outstanding | 20.4 | 26.9 | 9.3 | 15.3 | 15.5 | 11.4 | |
| Implied Stock Price | 4,955.00 | 6,150.00 | 4,460.00 | 12,950.00 | 12,760.00 | 8,330.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 4,955.00 | 6,150.00 | 4,460.00 | 12,950.00 | 12,760.00 | 8,330.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |